Treatment OutcomeOutcome Assessment (Health Care)Retrospective StudiesPregnancy OutcomeFollow-Up StudiesFund RaisingPrognosisFinancing, OrganizedAntitubercular AgentsProspective StudiesTime FactorsDirectly Observed TherapyOutcome and Process Assessment (Health Care)Cognitive TherapyFinancing, GovernmentCohort StudiesRisk FactorsTreatment FailureSurvival AnalysisCombined Modality TherapySurvival RateSeverity of Illness IndexRecurrenceCapital FinancingPredictive Value of TestsPatient ComplianceUnited StatesTuberculosis, PulmonaryExtensively Drug-Resistant TuberculosisFinancial ManagementTuberculosis, Multidrug-ResistantRandomized Controlled Trials as TopicPregnancyHIV InfectionsMultivariate AnalysisSubstance-Related DisordersBuprenorphineTuberculosisInfant, NewbornKaplan-Meier EstimateOpioid-Related DisordersLogistic ModelsPsychotherapySubstance Abuse Treatment CentersAge FactorsQuality of LifeAlcoholismDrug Therapy, CombinationPatient SatisfactionRisk AssessmentHospitals, Chronic DiseaseNeoplasm StagingTemperanceInternational CooperationAntineoplastic Combined Chemotherapy ProtocolsPsychiatric Status Rating ScalesGovernment ProgramsRemission InductionFinancial SupportClinical Trials as TopicAnti-Retroviral AgentsPatient DropoutsImplosive TherapyCocaine-Related DisordersRegression AnalysisDisease-Free SurvivalPostoperative ComplicationsMethadoneDepressive Disorder, MajorIncidenceLongitudinal StudiesResearch DesignResidential TreatmentRetreatmentProportional Hazards ModelsCost-Benefit AnalysisReproducibility of ResultsChi-Square DistributionGenotypePilot ProjectsCoinfectionProgram EvaluationUnited NationsSex FactorsPatient SelectionInvestmentsEthambutolResearch Support as TopicBehavior TherapyMedication AdherenceAnti-HIV AgentsNeoplasm Recurrence, LocalRegistriesDisease ProgressionDelivery of Health CarePrecursor Cell Lymphoblastic Leukemia-LymphomaMotivationAnalysis of VarianceRibavirinOpiate Substitution Treatment